Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3017]

Innovative treatments for solid tumours – TTFields as a therapeutic modality

Dr Giuseppe Lombardi, Dr Helen Bulbeck, Prof Dean Fennell and Dr Tadeja Urbanic...

Innovative treatments for solid tumours – TTFields as a therapeutic modality ( Dr Giuseppe Lombardi, Dr Helen Bulbeck, Prof Dean Fennell and Dr Tadeja Urbanic-Purkart )

Atezolizumab with platinum-based CT and niraparib show no improvement in...

Dr Antonio Gonzalez Martin - Cancer Center Clínica Universidad de Navarra...

Atezolizumab with platinum-based CT and niraparib show no improvement in survival for rOC ( Dr Antonio Gonzalez Martin - Cancer Center Clínica Universidad de Navarra, Madrid, Spain )

Literature search and synthesis of literature

Dr Don Thiwanka Wijeratne - Queen's University, Canada

Literature search and synthesis of literature ( Dr Don Thiwanka Wijeratne - Queen's University, Canada )

Forming a team - How do I find a biostatistician in a LMIC or should I become...

Dr Bhawna Sirohi - Balco Medical Center, Raipur, India

Forming a team - How do I find a biostatistician in a LMIC or should I become one myself? ( Dr Bhawna Sirohi - Balco Medical Center, Raipur, India )

KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer

Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal

KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer ( Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal )

Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall...

Dr Neil Gross - MD Anderson Cancer Center, Houston, USA

Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC ( Dr Neil Gross - MD Anderson Cancer Center, Houston, USA )

PARPi combinations to treat patients with mCRPC

Prof Axel Merseburger, Prof Karim Fizazi, Prof Laura-Maria Krabbe and Prof...

PARPi combinations to treat patients with mCRPC ( Prof Axel Merseburger, Prof Karim Fizazi, Prof Laura-Maria Krabbe and Prof Gerhardt Attard )

Where do we stand with mCRPC?

Dr Neal Shore, Prof Neeraj Agarwal, Dr Pasquale Rescigno and Dr Friederike...

Where do we stand with mCRPC? ( Dr Neal Shore, Prof Neeraj Agarwal, Dr Pasquale Rescigno and Dr Friederike Schlurmann )

Induction chemotherapy added to chemoradiation improves PFS and OS in advanced...

Dr Mary McCormack - University College Hospital, London, UK

Induction chemotherapy added to chemoradiation improves PFS and OS in advanced cervical cancer ( Dr Mary McCormack - University College Hospital, London, UK )

Active surveillance for oesophageal cancer shows improved HRQoL compared to...

Dr Berend Van der Wilk - Erasmus MC Cancer Institute, Rotterdam, The Netherlands

Active surveillance for oesophageal cancer shows improved HRQoL compared to standard surgery ( Dr Berend Van der Wilk - Erasmus MC Cancer Institute, Rotterdam, The Netherlands )

Sotorasib and panitumumab demonstrate clinically meaningful benefit in KRAS...

Dr Filippo Pietrantonio - ‎The National Cancer Institute of Milan, Milan, Italy

Sotorasib and panitumumab demonstrate clinically meaningful benefit in KRAS G12C-mutated metastatic colorectal cancer ( Dr Filippo Pietrantonio - ‎The National Cancer Institute of Milan, Milan, Italy )

ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC

Dr Joshua Sabari, Dr Enriqueta Felip and Dr Alex Spira

ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC ( Dr Joshua Sabari, Dr Enriqueta Felip and Dr Alex Spira )

More from ecancer